フォロー
Jonas J. Staudacher
Jonas J. Staudacher
Charité - Universiätsmedizin Berlin - Division of Gastroenterology, Infectology and Rheumatology
確認したメール アドレス: charite.de
タイトル
引用先
引用先
Transforming growth factor β superfamily signaling in development of colorectal cancer
B Jung, JJ Staudacher, D Beauchamp
Gastroenterology 152 (1), 36-52, 2017
2312017
Increased stiffness of the tumor microenvironment in colon cancer stimulates cancer associated fibroblast-mediated prometastatic activin A signaling
J Bauer, MAB Emon, JJ Staudacher, AL Thomas, J Zessner-Spitzenberg, ...
Scientific reports 10 (1), 50, 2020
1182020
NFkB is essential for activin-induced colorectal cancer migration via upregulation of PI3K-MDM2 pathway
A Jana, NL Krett, G Guzman, A Khalid, O Ozden, JJ Staudacher, J Bauer, ...
Oncotarget 8 (23), 37377, 2017
822017
Activin and TGFβ use diverging mitogenic signaling in advanced colon cancer
J Bauer, O Ozden, N Akagi, T Carroll, DR Principe, JJ Staudacher, ...
Molecular cancer 14, 1-14, 2015
662015
The predictors of mortality and secular changes in management strategies in emphysematous gastritis
A Watson, V Bul, J Staudacher, R Carroll, C Yazici
Clinics and Research in Hepatology and Gastroenterology 41 (1), e1-e7, 2017
652017
Activin signaling is an essential component of the TGF-β induced pro-metastatic phenotype in colorectal cancer
JJ Staudacher, J Bauer, A Jana, J Tian, T Carroll, G Mancinelli, Ö Özden, ...
Scientific reports 7 (1), 5569, 2017
572017
Hypoxia-induced gene expression results from selective mRNA partitioning to the endoplasmic reticulum
JJ Staudacher, IS Naarmann-de Vries, SJ Ujvari, B Klinger, M Kasim, ...
Nucleic acids research 43 (6), 3219-3236, 2015
462015
Loss of TGFβ signaling promotes colon cancer progression and tumor-associated inflammation
DR Principe, B DeCant, J Staudacher, D Vitello, RJ Mangan, EA Wayne, ...
Oncotarget 8 (3), 3826, 2017
432017
Increased Frequency ofKRASMutations in African Americans Compared with Caucasians in Sporadic Colorectal Cancer
JJ Staudacher, C Yazici, V Bul, J Zeidan, A Khalid, Y Xia, N Krett, B Jung
Clinical and Translational Gastroenterology 8 (10), e124, 2017
372017
Expression of an oncogenic BARD1 splice variant impairs homologous recombination and predicts response to PARP-1 inhibitor therapy in colon cancer
O Ozden, F Bishehsari, J Bauer, SH Park, A Jana, SH Baik, JC Sporn, ...
Scientific reports 6 (1), 26273, 2016
312016
Multiorgan failure predicts mortality in emphysematous pancreatitis: a case report and systematic analysis of the literature
V Bul, C Yazici, JJ Staudacher, B Jung, BR Boulay
Pancreas 46 (6), 825-830, 2017
202017
Shutdown of achaete-scute homolog-1 expression by heterogeneous nuclear ribonucleoprotein (hnRNP)-A2/B1 in hypoxia
M Kasim, E Benko, A Winkelmann, R Mrowka, JJ Staudacher, PB Persson, ...
Journal of Biological Chemistry 289 (39), 26973-26988, 2014
122014
Activin in acute pancreatitis: Potential risk-stratifying marker and novel therapeutic target
JJ Staudacher, C Yazici, T Carroll, J Bauer, J Pang, N Krett, Y Xia, ...
Scientific reports 7 (1), 12786, 2017
92017
Erstmalige interdisziplinäre DKK-Programmplanung durch Zusammenschluss onkologischer Nachwuchsgruppen
MA Mäurer, T Huber, NP Sommer, I Mäurer, L Lazaridis, R Bodensohn, ...
Forum 37 (1), 19-23, 2022
82022
Increased stiffness of the tumor microenvironment in colon cancer leads to an increase in activin and metastatic potential
J Bauer, JJ Staudacher, G Mancinelli, N Krett, E Bashar, P Grippo, ...
Cancer Research 78 (13_Supplement), 177-177, 2018
72018
Author Correction: Increased stiffness of the tumor microenvironment in colon cancer stimulates cancer associated fibroblast-mediated prometastatic activin A signaling
J Bauer, MAB Emon, JJ Staudacher, AL Thomas, J Zessner-Spitzenberg, ...
Scientific Reports 10, 2020
52020
NFkB is essential for activin-induced colorectal cancer migration via upregulation of PI3K-MDM2 pathway. Oncotarget. 2017
A Jana, NL Krett, G Guzman, A Khalid, O Ozden, JJ Staudacher, J Bauer, ...
5
Importance of interdisciplinarity in modern oncology: results of a national intergroup survey of the Young Oncologists United (YOU)
M Mäurer, J Staudacher, R Meyer, I Mäurer, L Lazaridis, M Müther, ...
Journal of Cancer Research and Clinical Oncology 149 (12), 10075-10084, 2023
42023
Prognostic impact of activin subunit inhibin beta A in gastric and esophageal adenocarcinomas
JJ Staudacher, A Arnold, AA Kühl, M Pötzsch, S Daum, M Winterfeld, ...
BMC cancer 22 (1), 953, 2022
32022
Commentary: Activin and TGFβ use diverging mitogenic signaling in advanced colon cancer
J Bauer, JJ Staudacher, NL Krett, B Jung
Journal of rare diseases research & treatment 1 (1), 43, 2016
32016
現在システムで処理を実行できません。しばらくしてからもう一度お試しください。
論文 1–20